Wetzstein, Nils http://orcid.org/0000-0002-5589-4668
Diricks, Margo
Anton, Thomas B.
Andres, Sönke
Kuhns, Martin
Kohl, Thomas A.
Schwarz, Carsten
Lewin, Astrid
Kehrmann, Jan
Kahl, Barbara C.
Schmidt, Annika
Zimmermann, Stefan
Jansson, Moritz K.
Baron, Sophie A.
Schulthess, Bettina
Hogardt, Michael
Friesen, Inna
Niemann, Stefan
Wichelhaus, Thomas A.
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung
Frankfurter Forschungsförderung
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 25 January 2024
Accepted: 28 June 2024
First Online: 9 July 2024
Declarations
:
: This study has been approved by the local ethics committee of the University Hospital Frankfurt under file number 2022–672. As this was a retrospective study, no informed consent was necessary. The study has been conducted in accordance with the principles of the Helsinki Declaration.
: Not applicable.
: Nils Wetzstein, Margo Diricks, Thomas B. Anton, Sönke Andres, Thomas A. Kohl, Carsten Schwarz, Astrid Lewin, Barbara C. Kahl, Annika Schmidt, Stefan Zimmermann, Moritz K. Jansson, Sophie Baron, Bettina Schulthess, Inna Friesen, and Stefan Niemann have nothing to disclose.Martin Kuhns received institutional funding as National Reference Laboratory from the German Ministry of Health, institutional contracts with Bruker/Hain Liefescience, and INSTAND, and support for attending meetings from the German Ministry of Health. Jan Kehrmann received honoraria for lectures and support for travel from INSMED outside the submitted work. Michael Hogardt reports grants from Mukoviszidose Institut gGmbH and the German Federal Ministry of Health, honoraria for lectures from the Landesärztekammer Hessen and bioMérieux, and funding from Merck AG outside the submitted work. Thomas A. Wichelhaus reports research grants from BMBF, JPIAMR, Deutsche Krebshilfe, MSD as well as speaker fees and consulting honoraria from Insmed, Osartis, all outside the submitted work.